Reply to Seddon, Schaaf, and Hesseling.
Publication
, Journal Article
Dooley, KE; Mitnick, C; Degroote, MA; Obuku, E; Hamilton, CD; Makhene, M; Shah, S; Brust, JCM; Durakovic, N; Nuermberger, E ...
Published in: Clin Infect Dis
January 2013
Duke Scholars
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
January 2013
Volume
56
Issue
1
Start / End Page
168 / 169
Location
United States
Related Subject Headings
- Tuberculosis, Multidrug-Resistant
- Microbiology
- Humans
- Antitubercular Agents
- Animals
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Dooley, K. E., Mitnick, C., Degroote, M. A., Obuku, E., Hamilton, C. D., Makhene, M., … Efficacy Subgroup, RESIST-TB, . (2013). Reply to Seddon, Schaaf, and Hesseling. Clin Infect Dis, 56(1), 168–169. https://doi.org/10.1093/cid/cis820
Dooley, Kelly E., Carole Mitnick, Mary Ann Degroote, Ekwaro Obuku, Carol D. Hamilton, Mamodikoe Makhene, Sarita Shah, et al. “Reply to Seddon, Schaaf, and Hesseling.” Clin Infect Dis 56, no. 1 (January 2013): 168–69. https://doi.org/10.1093/cid/cis820.
Dooley KE, Mitnick C, Degroote MA, Obuku E, Hamilton CD, Makhene M, et al. Reply to Seddon, Schaaf, and Hesseling. Clin Infect Dis. 2013 Jan;56(1):168–9.
Dooley, Kelly E., et al. “Reply to Seddon, Schaaf, and Hesseling.” Clin Infect Dis, vol. 56, no. 1, Jan. 2013, pp. 168–69. Pubmed, doi:10.1093/cid/cis820.
Dooley KE, Mitnick C, Degroote MA, Obuku E, Hamilton CD, Makhene M, Shah S, Brust JCM, Durakovic N, Nuermberger E, Efficacy Subgroup, RESIST-TB. Reply to Seddon, Schaaf, and Hesseling. Clin Infect Dis. 2013 Jan;56(1):168–169.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
January 2013
Volume
56
Issue
1
Start / End Page
168 / 169
Location
United States
Related Subject Headings
- Tuberculosis, Multidrug-Resistant
- Microbiology
- Humans
- Antitubercular Agents
- Animals
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences